ALBIREO PHARMA, INC. Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Albireo Pharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q3 2022.
  • Albireo Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2022 was 20.7M shares, a 7.35% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 20.7M +1.42M +7.35% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 19.6M +362K +1.88% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 19.5M +327K +1.71% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 19.3M +190K +0.99% Dec 31, 2021 10-Q 2022-11-08
Q3 2021 19.3M +202K +1.06% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 19.2M +4.25M +28.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 19.2M +4.21M +28.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 19.1M +6.36M +49.9% Dec 31, 2020 10-K 2022-03-01
Q3 2020 19.1M +6.39M +50.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 15M +2.3M +18.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 15M +2.94M +24.4% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 12.7M +780K +6.51% Dec 31, 2019 10-K 2021-02-25
Q3 2019 12.7M +715K +5.98% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 12.7M +728K +6.09% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 12M +142K +1.19% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 12M +3.07M +34.5% Dec 31, 2018 10-Q 2019-11-06
Q3 2018 12M +3.09M +34.8% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 12M +3.1M +35% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 11.9M +5.6M +89.1% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 8.9M +2.61M +41.5% Dec 31, 2017 10-K 2019-03-06
Q3 2017 8.88M +6.74M +315% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 8.86M -55.3M -86.2% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 6.29M -57.9M -90.2% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 6.29M +6.29M Dec 31, 2016 10-K 2018-03-27
Q3 2016 2.14M +66.6K +3.21% Sep 30, 2016 10-K 2016-12-22
Q2 2016 64.1M +2M +3.21% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 64.1M +39.5M +161% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 0 -23.5M -100% Dec 31, 2015 10-K 2017-03-27
Q3 2015 2.07M -21M -91% Sep 30, 2015 10-K 2016-12-22
Q2 2015 62.2M +41M +194% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 24.6M +3.5M +16.6% Mar 31, 2015 10-Q/A 2015-06-01
Q4 2014 23.5M +2.38M +11.3% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 23.1M +2.01M +9.53% Sep 30, 2014 10-K 2015-12-22
Q2 2014 21.1M +2.22M +11.7% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 21.1M +6.91M +48.7% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 21.1M +6.9M +48.7% Dec 31, 2013 10-Q 2014-02-10
Q3 2013 21.1M +6.9M +48.7% Sep 30, 2013 10-K 2014-12-19
Q2 2013 18.9M +4.92M +35.2% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 14.2M -24.7M -63.5% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 14.2M -24.5M -63.4% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 14.2M +4.51M +46.7% Sep 30, 2012 10-K 2013-12-20
Q2 2012 14M -24.6M -63.8% Jun 30, 2012 10-Q/A 2012-09-12
Q1 2012 38.9M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 38.7M Dec 31, 2011 10-Q 2012-02-09
Q3 2011 9.66M -16.7M -63.4% Sep 30, 2011 10-K 2012-12-21
Q2 2011 38.6M Jun 30, 2011 10-Q 2011-08-09
Q3 2010 26.4M Sep 30, 2010 10-K 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.